Lisanti Capital Growth LLC Sells 2,130 Shares of Evolent Health, Inc. (NYSE:EVH)

Lisanti Capital Growth LLC trimmed its holdings in shares of Evolent Health, Inc. (NYSE:EVH) by 3.9% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 52,060 shares of the technology company’s stock after selling 2,130 shares during the period. Lisanti Capital Growth LLC’s holdings in Evolent Health were worth $1,707,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of EVH. NBC Securities Inc. boosted its position in Evolent Health by 16.6% during the 1st quarter. NBC Securities Inc. now owns 2,461 shares of the technology company’s stock valued at $81,000 after buying an additional 350 shares during the period. HMS Capital Management LLC boosted its holdings in shares of Evolent Health by 7.8% during the first quarter. HMS Capital Management LLC now owns 7,419 shares of the technology company’s stock worth $243,000 after purchasing an additional 538 shares during the period. Janney Capital Management LLC grew its stake in shares of Evolent Health by 7.6% in the first quarter. Janney Capital Management LLC now owns 9,543 shares of the technology company’s stock worth $313,000 after purchasing an additional 671 shares during the last quarter. Genesee Capital Advisors LLC increased its holdings in Evolent Health by 2.2% during the 4th quarter. Genesee Capital Advisors LLC now owns 38,390 shares of the technology company’s stock valued at $1,268,000 after purchasing an additional 825 shares during the period. Finally, ICA Group Wealth Management LLC bought a new position in Evolent Health during the 4th quarter valued at approximately $33,000.

Evolent Health Stock Up 0.4 %

NYSE:EVH traded up $0.07 during trading hours on Friday, reaching $19.69. 1,771,715 shares of the company traded hands, compared to its average volume of 2,007,183. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.57. The business’s 50-day moving average price is $22.22 and its two-hundred day moving average price is $28.17. Evolent Health, Inc. has a 1 year low of $17.98 and a 1 year high of $35.00. The stock has a market capitalization of $2.29 billion, a P/E ratio of -15.75 and a beta of 1.54.

Evolent Health (NYSE:EVH) last posted its quarterly earnings results on Thursday, May 9th. The technology company reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.12 by $0.04. Evolent Health had a positive return on equity of 6.90% and a negative net margin of 5.07%. The firm had revenue of $639.65 million during the quarter, compared to analyst estimates of $601.60 million. Analysts predict that Evolent Health, Inc. will post 0.9 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the company. Citigroup initiated coverage on Evolent Health in a research report on Monday, April 22nd. They issued a “buy” rating and a $40.00 price objective on the stock. JMP Securities cut their price target on shares of Evolent Health from $38.00 to $34.00 and set a “market outperform” rating on the stock in a report on Friday, May 10th. JPMorgan Chase & Co. cut their price target on shares of Evolent Health from $53.00 to $52.00 and set an “overweight” rating on the stock in a report on Friday, March 15th. Finally, Canaccord Genuity Group cut their price target on shares of Evolent Health from $44.00 to $41.00 and set a “buy” rating on the stock in a report on Friday, May 10th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and eleven have given a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $42.00.

Evolent Health Company Profile

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.